← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 2, 1999First marketed drug
Aug 20, 2018First NDA
Aug 20, 2018Last known activity
Oct 22, 2025
Timeline
1950s
- Jul 1, 1953
Biocodex— Founded
2010s
- Aug 20, 2018
stiripentol— NDA Organization
- Aug 20, 2018
stiripentol— NDA Secondary Org
Drugs by trial phase (9 distinct, 17 trials)
Phase 4 (4 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Approved for
Marketed drugs (1)
Recent trials (19)
- NCT07168434Lead sponsorPhase 3Oct 22, 2025
- NCT07168434OfficialPhase 3Oct 22, 2025
- NCT07176832Lead sponsorPhase 1Jun 1, 2025
- NCT06465472Lead sponsorPhase 3Aug 31, 2024
- NCT06451913Lead sponsorPhase 4Jun 30, 2024
- NCT06568588CollaboratorPhase 2Jan 6, 2024
- NCT05735951Lead sponsorPhase 1Mar 25, 2023
- NCT05419180Lead sponsorPhase 4Oct 13, 2022
- NCT03819647Lead sponsorPhase 2May 31, 2019
- NCT03866928Lead sponsorPhase 1Feb 12, 2019
- NCT03539913Lead sponsorPhase 4Jun 19, 2017
- NCT03539913Study directorPhase 4Jun 19, 2017
- NCT04786938CollaboratorPhase 4Apr 7, 2016
- NCT02147548Lead sponsorPhase 3Dec 1, 2013
- NCT02143895Lead sponsorPhase 3Dec 1, 2013
Details
- Founded
- Gentilly, FR Jul 1, 1953
- First NDA
- Aug 20, 2018
- Last known activity
- Oct 22, 2025
Designations held
- Orphan drug
- Priority review